Biocon Biologics to present at 43rd Annual JP Morgan Healthcare Conference Ruchika Sharma10 Jan 2025 1:30 PM ISTKarnataka: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, will present at the 43rd Annual J.P....
Biocon Biologics gets Japenese nod for Psoriasis Vulgaris injection Ustekinumab BS Ruchika Sharma7 Jan 2025 1:15 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the...
Approval of Biocon Biologics Yesintek recommended by EMA Committee Ruchika Sharma16 Dec 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the European...
Biocon Biologics recognized as Asia IP Elite for 2024 by IAM Ruchika Sharma12 Dec 2024 12:39 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Limited, has announced that it has once again been recognized as an Asia IP Elite for...
Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel Farhat Nasim4 Dec 2024 5:00 PM ISTNew Delhi: Over the last five years, six pharmaceutical suppliers have been blacklisted for providing substandard medicines to Jan Aushadhi Kendras...
USFDA approves Biocon Biologics Yesintek for Crohn's disease, Ulcerative Colitis, Plaque Psoriasis, Psoriatic Arthritis Ruchika Sharma2 Dec 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the U.S. Food ...
Biocon Biologics Bengaluru drug substance facility classified as VAI Ruchika Sharma4 Nov 2024 12:30 PM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (USFDA) has classified Biocon Biologics' Drug Substance Facility at Biocon...
Biocon Biologics refinances USD 1.1 billion long term debt through USD Bonds new syndicated facility Ruchika Sharma5 Oct 2024 11:30 AM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Limited, has announced the successful pricing of Biocon Biologics' debut USD 800 million...
USFDA concludes inspection at Biocon Biologics Malaysia Insulins facility Ruchika Sharma30 Sept 2024 1:15 PM ISTKarnataka: Biocon Biologics has announced that the US Food and Drug Administration (USFDA) has completed a cGMP inspection at the Company's...
Biocon Biologics announces New Dermatology data to be presented at EADV Congress 2024 Ruchika Sharma25 Sept 2024 2:48 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd has announced new dermatology data presented at the European Academy of...
Biocon Biologics secures market entry for Bmab 1200 in Europe, UK, Canada, Japan Ruchika Sharma29 Aug 2024 12:30 PM ISTBangalore: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd, announced today that the...
Biocon Biologics plans to raise Rs 4,000-4,500 crore via local bonds: Report Ruchika Sharma8 July 2024 12:30 PM ISTBiocon Biologics Ltd., a biopharmaceutical company, is considering raising between Rs 4,000 crore and Rs 4,500 crore from India’s local-currency bond...
